Figure 7.

(A and B) Pretreatment of BEAS-2B cells with RPMI media or low-molecular-weight heparin (LMWH) (10 μg/ml) for 1 hour followed by treatment with media, LPS (A), or TNF-α (B) for 3 hours. (C) Pretreatment of BEAS-2B cells with RPMI media or syndecan-4 (2.5 μg/ml) for 1 hour followed by treatment with media or TNF-α for 3 hours. Values are the mean ± SEM with n = 6. An (a) shows groups that are different from the control group, and a (b) shows differences between LPS or TNF-α treatment groups using the Kruskal-Wallis test with Dunn's multiple comparison test with P ≤ 0.05.